𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A clinical perspective of IL-1β as the gatekeeper of inflammation

✍ Scribed by Charles A. Dinarello

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
254 KB
Volume
41
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The CDK domain of p21 is a suppressor of
The CDK domain of p21 is a suppressor of IL-1β-mediated inflammation in activated macrophages
✍ John C. Scatizzi; Melissa Mavers; Jack Hutcheson; Brittany Young; Bo Shi; Richar 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB

## Abstract Significant morbidity and mortality can be attributed to inflammatory diseases; therefore, a greater understanding of the mechanisms involved in the progression of inflammation is crucial. Here, we demonstrate that p21^(WAF1/CIP1)^, an established suppressor of cell cycle progression, i

Modulation of the cellular pharmacology
Modulation of the cellular pharmacology and clinical toxicity of 1-β-D-arabinofuranosylcytosine
✍ Howell, Stephen B. ;Streifel, Jerome A. ;Pfeifle, Craig E. 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 592 KB

The effect of thymidine (dThd) and hydroxyurea (HU) on the cellular metabolism of 1 -P-D-arabinofuranosylcytosine (Ara-C) was investigated in the human promyelocytic cell line HL-60. Both dThd and HU increased the cellular uptake and rate of formation of Ara-CTP. Measurement of ribo-and deoxyribonuc